Carlos F. Barbas III
Carlos F. Barbas III (5 November 1964 – 24 June 2014) was chair professor of the Janet and Keith Kellogg II and a chemist at the Scripps Research Institute. Barbas developed new therapies that can target HIV-1 and some kinds of cancer which went into clinical trials.
Carlos F. Barbas III | |
|---|---|
| Born | November 5, 1964 St. Petersburg, Florida |
| Died | June 24, 2014 (aged 49) |
| Alma mater | Eckerd College Texas A&M University Pennsylvania State University |
| Scientific career | |
| Fields | Synthetic organic chemistry Bio-therapeutics |
| Institutions | The Scripps Research Institute |
| Thesis | Overproduction and utilization of enzymes in synthetic organic chemistry. (1989) |
| Doctoral advisor | Chi-Huey Wong |
| Other academic advisors | Stephen J. Benkovic |
| Notable students | Benjamin List |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.